| Dr Chad Braden, MD | |
|
9001 Summa Ave, Baton Rouge, LA 70809-3726 | |
| (225) 761-5480 | |
| (225) 761-5487 |
| Full Name | Dr Chad Braden |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 9001 Summa Ave, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447217336 | NPI | - | NPPES |
| 1432822 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD13519R (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Medical Center - Baton Rouge | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
LEE011, a small-molecule inhibitor of cyclin-dependent kinases (CDK) 4/6 being developed by Novartis Oncology, showed promising results in drug-resistant melanoma and drug-resistant breast cancer when tested in combination with other targeted therapies, and based on these preclinical results, several phase I clinical trials were launched recently, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held October 19-23.
A new rapid Coronavirus diagnosis tool is to be rolled out across care homes and laboratories from next week.
Medical device company Vertos Medical Inc. has announced the unveiling of 12-week clinical data from its prospective, 75-patient MiDAS I (mild Decompression Alternative to open Surgery) study that further validate the safety and efficacy of mild for the treatment of lumbar spinal stenosis (LSS). Consistent with the positive six-week study results released in March and May, the new MiDAS I data demonstrate that mild patients continued to experience statistically significant improvement in pain, physical function and mobility 12 weeks following treatment.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results. The Engenex Negative Pressure Wound Therapy (NPWT) system's Bio-Dome wound interface showed superior tensile strength and lower simulated bioadhesion when compared with GranuFoam (polyurethane foam).
› Verified 6 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
LEE011, a small-molecule inhibitor of cyclin-dependent kinases (CDK) 4/6 being developed by Novartis Oncology, showed promising results in drug-resistant melanoma and drug-resistant breast cancer when tested in combination with other targeted therapies, and based on these preclinical results, several phase I clinical trials were launched recently, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held October 19-23.
A new rapid Coronavirus diagnosis tool is to be rolled out across care homes and laboratories from next week.
Medical device company Vertos Medical Inc. has announced the unveiling of 12-week clinical data from its prospective, 75-patient MiDAS I (mild Decompression Alternative to open Surgery) study that further validate the safety and efficacy of mild for the treatment of lumbar spinal stenosis (LSS). Consistent with the positive six-week study results released in March and May, the new MiDAS I data demonstrate that mild patients continued to experience statistically significant improvement in pain, physical function and mobility 12 weeks following treatment.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results. The Engenex Negative Pressure Wound Therapy (NPWT) system's Bio-Dome wound interface showed superior tensile strength and lower simulated bioadhesion when compared with GranuFoam (polyurethane foam).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chad Braden, MD 9001 Summa Ave, Baton Rouge, LA 70809-3726 Ph: (225) 761-5200 | Dr Chad Braden, MD 9001 Summa Ave, Baton Rouge, LA 70809-3726 Ph: (225) 761-5480 |
News Archive
LEE011, a small-molecule inhibitor of cyclin-dependent kinases (CDK) 4/6 being developed by Novartis Oncology, showed promising results in drug-resistant melanoma and drug-resistant breast cancer when tested in combination with other targeted therapies, and based on these preclinical results, several phase I clinical trials were launched recently, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held October 19-23.
A new rapid Coronavirus diagnosis tool is to be rolled out across care homes and laboratories from next week.
Medical device company Vertos Medical Inc. has announced the unveiling of 12-week clinical data from its prospective, 75-patient MiDAS I (mild Decompression Alternative to open Surgery) study that further validate the safety and efficacy of mild for the treatment of lumbar spinal stenosis (LSS). Consistent with the positive six-week study results released in March and May, the new MiDAS I data demonstrate that mild patients continued to experience statistically significant improvement in pain, physical function and mobility 12 weeks following treatment.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results. The Engenex Negative Pressure Wound Therapy (NPWT) system's Bio-Dome wound interface showed superior tensile strength and lower simulated bioadhesion when compared with GranuFoam (polyurethane foam).
› Verified 6 days ago
Dr. Roderick A. Hart Sr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3801 North Blvd, Baton Rouge, LA 70806 Phone: 601-454-9462 | |
Dr. Brent Oliver Campanella, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5131 Essen Ln, Baton Rouge, LA 70809 Phone: 225-769-0043 Fax: 225-769-0133 | |
Robert Dwight Brower, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7037 Woodstock Dr, Baton Rouge, LA 70809 Phone: 225-975-8680 | |
Kristin Wemple Morvant, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 16777 Medical Center, Baton Rouge, LA 70816 Phone: 225-754-3278 | |
Dr. Tamika Session Mayo, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3401 North Blvd, Ste 360, Baton Rouge, LA 70806 Phone: 225-381-2712 Fax: 225-381-2715 | |
Gregory F Ferrara, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13828 Coursey Blvd, Baton Rouge, LA 70817 Phone: 225-751-1544 Fax: 225-751-1909 | |
James Michael Robinson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7566 Picardy Ave, Baton Rouge, LA 70808 Phone: 225-765-5500 Fax: 225-256-1400 |